SEC Form 4

FORM 4


[ ] Check this box if no longer
subject to Section 16. Form 4 or Form
5 obligations may continue.
See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549


STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

OMB APPROVAL


OMB Number: 3235-0287
Expires: December 31, 2001
Estimated average burden
hours per response. . . . . 0.5

1. Name and Address of Reporting Person*
MacLean, Robert     G.

(Last)                      (First)                      (Middle)

One Boston Scientific Place

(Street)

Natick, MA     01760-1537

(City)                      (State)                      (Zip)

USA

2. Issuer Name and Ticker
    or Trading Symbol

Boston Scientific Corporation   (BSX)

3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)

4. Statement for
    (Month/Day/Year)

    March 17, 2003

5. If Amendment,
    Date of Original
    (Month/Year)

6. Relationship of Reporting Person(s) to Issuer

(Check all applicable)


                        Director                           10% Owner
           X          Officer                             Other

Officer/Other
Description           Senior Vice President, Human Resources

7. Individual or Joint/Group
    Filing (Check Applicable Line)

X   Individual Filing
      Joint/Group Filing

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security
    (Instr. 3)

2. Transaction Date
    (Month/Day/Year)

3. Transaction
    Code
    and
    Voluntary
    Code
    (Instr. 8)

Code  |  V    

4. Securities Acquired (A) or Disposed (D) Of
    (Instr. 3, 4, and 5)




        Amount      |         A/D         |         Price          

5. Amount of
    Securities
    Beneficially
    Owned at
    End of Month

    (Instr. 3 and 4)

6. Owner-
    ship
    Form:
    Direct(D)
    or
    Indirect (I)

    (Instr. 4)

7. Nature of
     Indirect
     Beneficial
     Ownership

    (Instr. 4)

Common Stock

03/17/2003

   M |     

40,000.00   |           A           |   $20.69        


D


Common Stock

03/17/2003

S (1) |     

40,000.00   |           D           |   $45.00        


D


Common Stock

03/18/2003

   M |     

20,000.00   |           A           |   $20.69        


D


Common Stock

03/18/2003

S (1) |     

20,000.00   |           D           |   $46.70        

17,670.00

D


Common Stock


 


3,601.00

I

By 401(k) (2)








Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

(over)
SEC 1474 (3-99)

MacLean, Robert G. - March 2003

Form 4 (continued)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
    (Instr. 3)

2. Conver-
    sion or
    Exercise
    Price of
    Deri-
    vative
    Security

3. Transaction
    Date

    (Month/
    Day/
    Year)

4. Transaction
    Code
    and
    Voluntary (V)
    Code
    (Instr.8)




Code | V    

5. Number of Derivative
    Securities Acquired (A)
    or Disposed (D) Of

    (Instr. 3,4 and 5)

6. Date Exercisable(DE) and
    Expiration Date(ED)
    (Month/Day/Year)







  (DE)     |     (ED)  

7. Title and Amount of
    Underlying Securities
    (Instr. 3 and 4)

8. Price
    of
    Derivative
    Security
    (Instr.5)

9. Number of
    Derivative
    Securities
    Beneficially
    Owned
    at End of
    Month
    (Instr.4)

10.
Owner-
ship
Form of
Deriv-
ative
Security:
Direct
(D)
or
Indirect
(I)

11. Nature of
      Indirect
      Beneficial
      Ownership
      (Instr.4)

Stock Option (Right to Buy)

$20.69

03/17/2003

   M |     

    (D) 40,000.00

Varies (3) | 05/09/2006

Common Stock - 40,000.00



D


Stock Option (Right to Buy)

$20.69

03/18/2003

   M |     

    (D) 20,000.00

Varies (3) | 05/09/2006

Common Stock - 20,000.00


0.00

D













Explanation of Responses :

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
        See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed. If space is insufficient,
            See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB number.

/s/ Lawrence J. Knopf, Attorney-in-fact
Robert G. MacLean

________________________________            03-19-2003    
** Signature of Reporting Person                         Date



Page 2
SEC 1474 (3-99)

MacLean, Robert G. - March 2003

Form 4 (continued)

FOOTNOTE Descriptions for Boston Scientific Corporation (BSX)

Form 4 - March 2003

Robert G. MacLean
One Boston Scientific Place

Natick, MA 01760-1537

Explanation of responses:

(1)   This sale was effected pursuant to a trading plan under Rule 10b5-1 which was adopted by the reporting person.
(2)   Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Savings Plan.
(3)   Grant to the reporting person to buy a specified number of shares of Common Stock exercisable 10% on May 9, 1997, 30% on May 9, 1998, 50% on May 9, 1999, 75% on May 9, 2000 and 100% on May 9, 2001, the anniversary date of this grant.

Page 3